609 related articles for article (PubMed ID: 29746711)
1. A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
Jang SM; Gharibian KN; Lewis SJ; Fissell WH; Tolwani AJ; Mueller BA
J Clin Pharmacol; 2018 Oct; 58(10):1254-1265. PubMed ID: 29746711
[TBL] [Abstract][Full Text] [Related]
2. Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
Lewis SJ; Kays MB; Mueller BA
J Clin Pharmacol; 2016 Oct; 56(10):1277-87. PubMed ID: 26919659
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Exposure Profiles in Trials Comparing Intensity of Continuous Renal Replacement Therapy.
Jang SM; Pai MP; Shaw AR; Mueller BA
Crit Care Med; 2019 Nov; 47(11):e863-e871. PubMed ID: 31397714
[TBL] [Abstract][Full Text] [Related]
4. What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
Delattre IK; Hites M; Laterre PF; Dugernier T; Spapen H; Wallemacq PE; Jacobs F; Taccone FS
Int J Antimicrob Agents; 2020 Oct; 56(4):106113. PubMed ID: 32721604
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy.
Lewis SJ; Mueller BA
BMC Nephrol; 2024 Feb; 25(1):73. PubMed ID: 38413858
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic Dosing in Continuous Renal Replacement Therapy.
Shaw AR; Mueller BA
Adv Chronic Kidney Dis; 2017 Jul; 24(4):219-227. PubMed ID: 28778361
[TBL] [Abstract][Full Text] [Related]
7. Optimal antipseudomonal ꞵ-lactam drug dosing recommendations in critically-ill Asian patients receiving CRRT.
Jang SM; Lewis SJ; Rhie SJ
J Crit Care; 2022 Dec; 72():154172. PubMed ID: 36270240
[TBL] [Abstract][Full Text] [Related]
8. An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy.
Sember AM; LoFaso ME; Lewis SJ
J Crit Care; 2022 Jun; 69():154011. PubMed ID: 35202996
[TBL] [Abstract][Full Text] [Related]
9. Time Above All Else: Pharmacodynamic Analysis of β-Lactams in Critically Ill Patients.
Landmesser KB; Clark JA; Burgess DS
J Clin Pharmacol; 2022 Apr; 62(4):479-485. PubMed ID: 34614542
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.
Shea KM; Cheatham SC; Smith DW; Wack MF; Sowinski KM; Kays MB
Ann Pharmacother; 2009 Nov; 43(11):1747-54. PubMed ID: 19809009
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo Simulation Methodologies for β-Lactam/β-Lactamase Inhibitor Combinations: Effect on Probability of Target Attainment Assessments.
Kidd JM; Stein GE; Nicolau DP; Kuti JL
J Clin Pharmacol; 2020 Feb; 60(2):172-180. PubMed ID: 31423601
[TBL] [Abstract][Full Text] [Related]
12. Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study.
Chaijamorn W; Charoensareerat T; Srisawat N; Pattharachayakul S; Boonpeng A
J Intensive Care; 2018; 6():61. PubMed ID: 30221005
[TBL] [Abstract][Full Text] [Related]
13. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
Kim A; Kuti JL; Nicolau DP
Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
[TBL] [Abstract][Full Text] [Related]
14. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic model for β-lactam regimens used in surgical prophylaxis: model-based evaluation of standard dosing regimens.
Song X; Long M
Int J Clin Pharm; 2018 Oct; 40(5):1059-1071. PubMed ID: 30117081
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Sun HK; Kuti JL; Nicolau DP
Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
[TBL] [Abstract][Full Text] [Related]
18. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
Gharibian KN; Mueller BA
Clin Nephrol; 2016 Jul; 86(7):43-50. PubMed ID: 27251341
[TBL] [Abstract][Full Text] [Related]
19. Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function.
Thabit AK; Grupper M; Nicolau DP; Kuti JL
J Pharm Pract; 2017 Dec; 30(6):593-599. PubMed ID: 29121839
[TBL] [Abstract][Full Text] [Related]
20. Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation.
Eagye KJ; Kuti JL; Dowzicky M; Nicolau DP
Clin Ther; 2007 May; 29(5):889-899. PubMed ID: 17697907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]